Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.

Libre PE, Della-Latta P, Chin NX.

J Cataract Refract Surg. 2003 Sep;29(9):1791-4.

PMID:
14522303
2.

Nonsusceptible Streptococcus pneumoniae in children with chronic otitis media with effusion and recurrent otitis media undergoing ventilating tube placement.

Haddad J Jr, Saiman L, San Gabriel P, Chin NX, Whittier S, Deeter RG, Takoudes TG, Keller JL, Della-Latta P.

Pediatr Infect Dis J. 2000 May;19(5):432-7.

PMID:
10819339
3.

Penicillin-nonsusceptible pneumococcus in acute otitis media in New York City.

Haddad J Jr, Saiman L, Chin NX, Della-Latta P.

Otolaryngol Head Neck Surg. 1999 Jul;121(1):27-30.

PMID:
10388872
4.

A survey of dermatophytes isolated from human patients in the United States from 1993 to 1995.

Weitzman I, Chin NX, Kunjukunju N, Della-Latta P.

J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):255-61.

PMID:
9704838
6.

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper C Jr, Fothergill A, McGinnis MR, Menezes P, Messer SA, Nelson PW, Odds FC, Pasarell L, Peter J, Pfaller MA, Rex JH, Rinaldi MG, Shankland GS, Walsh TJ, Weitzman I.

J Clin Microbiol. 1997 Jan;35(1):139-43.

7.

Postantibiotic effect of ceftibuten on respiratory pathogens.

Chin NX, Huang HB, Neu HC.

Pediatr Infect Dis J. 1995 Jul;14(7 Suppl):S84-7.

PMID:
7567315
8.
9.

In vitro activity of the new fluoroquinolone CP-99,219.

Neu HC, Chin NX.

Antimicrob Agents Chemother. 1994 Nov;38(11):2615-22.

10.

In vitro activity of fleroxacin in combination with other antimicrobial agents.

Neu HC, Chin NX.

Am J Med. 1993 Mar 22;94(3A):9S-16S. Review.

PMID:
8452190
11.

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.

Neu HC, Chin NX, Huang HB.

Antimicrob Agents Chemother. 1993 Mar;37(3):566-73.

12.

In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.

Gu JW, Fang W, Chin NX, Neu HC.

Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):613-20.

PMID:
1330421
13.

In vitro antimicrobial activity of the new antibiotic vermisporin.

Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):755-7.

PMID:
1425739
14.

In vitro activity of MC-352, a new 16-membered macrolide.

Chin NX, Neu HC.

Antimicrob Agents Chemother. 1992 Aug;36(8):1699-702.

15.

In vitro activity and beta-lactamase stability of LJC 10,627.

Neu HC, Gu JW, Fang W, Chin NX.

Antimicrob Agents Chemother. 1992 Jul;36(7):1418-23.

16.

Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.

Yu KW, Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):652-9.

PMID:
1396779
17.

Post-antibiotic effect of the new streptogramin RP 59500.

Chin NX, Neu HC.

Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):642-5.

PMID:
1396777
18.

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.

Neu HC, Chin NX, Gu JW.

J Antimicrob Chemother. 1992 Jul;30 Suppl A:83-94.

PMID:
1328138
19.

In vitro activity and susceptibility to hydrolysis of S-1006.

Neu HC, Gu JW, Fang W, Chin NX.

Antimicrob Agents Chemother. 1992 Jun;36(6):1336-41.

20.

In vitro activity of OPC-17116.

Neu HC, Fang W, Gu JW, Chin NX.

Antimicrob Agents Chemother. 1992 Jun;36(6):1310-5.

21.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

Chin NX, Gu JW, Fang W, Neu HC.

Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):331-7.

PMID:
1611848
22.

In vitro activity of the new glycopeptide decaplanin.

Neu HC, Chin NX, Niu WW.

Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458-62.

PMID:
1330562
23.

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

Chin NX, Zhang YX, Neu HC.

Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):417-24.

PMID:
1797456
24.

In vitro activity of cefcanel versus other oral cephalosporins.

Chin NX, Gu JW, Neu HC.

Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):676-82.

PMID:
1748125
25.

In vitro activity of Ro 09-1428 compared to other cephalosporins.

Chin NX, Gu JW, Fang W, Neu HC.

Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):669-75.

PMID:
1748124
26.

Antibacterial activity of rokitamycin compared with that of other macrolides.

Yu KW, Briones F, Chin NX, Neu HC.

Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):331-5.

PMID:
1889182
27.
28.

In vitro activity of sparfloxacin.

Chin NX, Gu JW, Yu KW, Zhang YX, Neu HC.

Antimicrob Agents Chemother. 1991 Mar;35(3):567-71.

29.

In vitro activity of an oxycephem OCP 9-176 compared with its sulfur analog and other beta-lactams.

Gu JW, Chin NX, Neu HC.

Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):135-40.

PMID:
1873972
30.

In vitro activity of LY264826 compared to other glycopeptides and daptomycin.

Chin NX, Neu HC.

Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):181-4.

PMID:
1651826
31.

In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.

Chin NX, Gu JW, Fang W, Neu HC.

Antimicrob Agents Chemother. 1991 Feb;35(2):259-66.

32.

Antimicrobial effects of the combination of ceftibuten and an orally absorbed penem SCH 29482.

Chin NX, Gu JW, Neu HC.

Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):79-83.

PMID:
2013213
33.

Combination of ofloxacin and other antimicrobial agents.

Chin NX, Neu HC.

J Chemother. 1990 Dec;2(6):343-7.

PMID:
2093103
34.

Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin.

Chin NX, Yu KW, Neu HC.

Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):841-6.

PMID:
2086221
35.

In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.

Chin NX, Gu JW, Neu HC.

Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):685-91.

PMID:
2226499
36.

Comparative in vitro activity of the new fluoroquinolone BMY-40062.

Chin NX, Neu H.

Eur J Clin Microbiol Infect Dis. 1990 Aug;9(8):620-4.

PMID:
2120060
37.

Activity of cephalosporins against coagulase-negative staphylococci.

Chin NX, Neu NM, Neu HC.

Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):67-9.

PMID:
2331853
38.

Resistance to ciprofloxacin appearing during therapy.

Chin NX, Clynes N, Neu HC.

Am J Med. 1989 Nov 30;87(5A):28S-31S.

PMID:
2511760
39.

Tazobactam prevention of emergence of resistance.

Neu HC, Niu WW, Chin NX.

Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):477-80. No abstract available.

PMID:
2560419
40.

Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.

Neu HC, Saha G, Chin NX.

Antimicrob Agents Chemother. 1989 Oct;33(10):1795-800.

41.

In vitro activity of ME1228, a new parenteral cephalosporin.

Neu HC, Saha G, Chin NX.

Antimicrob Agents Chemother. 1989 Aug;33(8):1260-7.

42.

In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactams.

Chin NX, Neu HC.

J Chemother. 1989 Jul;1(4 Suppl):90-2. No abstract available.

PMID:
16312319
43.

In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.

Neu HC, Novelli A, Chin NX.

Antimicrob Agents Chemother. 1989 Jul;33(7):1009-18.

44.

Comparative in vitro activity of a new quinolone, AM-1091.

Neu HC, Novelli A, Chin NX.

Antimicrob Agents Chemother. 1989 Jul;33(7):1036-41.

45.
46.

In vitro activity of S-ofloxacin.

Neu HC, Chin NX.

Antimicrob Agents Chemother. 1989 Jul;33(7):1105-7.

47.

In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.

Neu HC, Chin NX.

Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):644-50.

PMID:
2506029
48.

Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.

Neu HC, Saha G, Chin NX.

Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):283-5.

PMID:
2791491
49.

In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.

Chin NX, Neu HC.

J Antimicrob Chemother. 1989 Mar;23 Suppl C:95-101.

PMID:
2786520
50.

In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.

Neu HC, Chin NX, Novelli A.

Antimicrob Agents Chemother. 1988 Nov;32(11):1666-75.

Supplemental Content

Support Center